Qiying Dai, M.D.

The most important feature of a good doctor, to me, is perspective. Listening to patients, understanding their perspective and providing care specific to their needs are my guiding principles in work life.

My medical training and research interest focused on management of atrial fibrillation and cardiomyopathy. My experience in both a community-based hospital and an academic center provided me with the perspective of managing various medical situations.

Education

• Nanjing Medical University

Residency

• Internal Medicine, Metrowest Medical Center

Fellowships

• General Cardiology, St. Vincent Hospital
• Cardiac Electrophysiology, Mayo Clinic School of Graduate Medical Education

Certifications

• American Board of Cardiovascular Disease
• American Board of Internal Medicine

Membership

• Heart Rhythm Society

• Atrial fibrillation
• Intracardiac defibrillator
• Pacemaker implantation
• Supraventricular tachycardia and bradycardia

• Left bundle branch area pacing for heart failure patients requiring cardiac resynchronization therapy: A meta-analysis, August 2023.
• Association of atrial fibrillation burden with in-hospital outcomes in patients with Takotsubo cardiomyopathy, April 2023.
• Usefulness of self-reported physical activity and clinical outcomes in older patients with atrial fibrillation, October 2022.
• Meta-analysis of randomized clinical trials comparing the impact of implantable loop recorder versus usual care after ischemic stroke for detection of atrial fibrillation and stroke risk, October 2021.
• Mortality in stable coronary disease in patients with intermediate- or high-risk myocardial perfusion imaging, January 2021.